ALERT

Serious adverse effects resulting from the treatment with thalidomide prompted modern drug legislation more than 40 years ago. Post-marketing spontaneous reporting systems for suspected adverse drug reactions (ADRs) have been a cornerstone to detect safety signals in pharmacovigilance. It has become evident that adverse effects of drugs may be detected too late, when millions of persons have already been exposed.

In this project, an alternative approach for the detection of ADR signals will be developed. Rather than relying on the physician's capability and willingness to recognize and report suspected ADRs, the system will systematically calculate the occurrence of disease (potentially ADRs) during specific drug use based on data available in electronic patient records. In this project, electronic health records (EHRs) of over 30 million patients from several European countries will be available. In an environment where rapid signal detection is feasible, rapid signal assessment is equally important. To rapidly assess signals, a number of resources will be used to substantiate the signals: causal reasoning based on information in the EHRs, semantic mining of the biomedical literature, and computational analysis of biological and chemical information (drugs, targets, anti-targets, SNPs, pathways, etc.).

The overall objective of this project is the design, development and validation of a computerized system that exploits data from electronic healthcare records and biomedical databases for the early detection of adverse drug reactions. The ALERT system will generate signals using data and text mining, epidemiological and other computational techniques, and subsequently substantiate these signals in the light of current knowledge of biological mechanisms and in silico prediction capabilities. The system should be able to detect signals better and faster than spontaneous reporting systems and should allow for identification of subpopulations at higher risk for ADRs.

For further information, please visit:

Project co-ordinator:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Partners:

  • SOCIETA SERVIZI TELEMATICI SRL
  • UNIVERSIDADE DE AVEIRO
  • THE UNIVERSITY OF NOTTINGHAM
  • PHARMO COOPERATIE UA
  • AARHUS UNIVERSITETSHOSPITAL, AARHUS SYGEHUS
  • UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
  • UNIVERSITAT POMPEU FABRA
  • IRCCS CENTRO NEUROLESI BONINO PULEJO
  • FUNDACIO IMIM
  • LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE
  • ASTRAZENECA AB
  • UNIVERSITE VICTOR SEGALEN BORDEAUX II
  • AGENZIA REGIONALE DI SANITA
  • UNIVERSITA DEGLI STUDI DI MILANO - BICOCCA

Timetable: from 02/2008 – to 07/2011

Total cost: € 5.880.600

EC funding: € 4.500.000

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)

Related news article:

Most Popular Now

Leading Health Systems Sign On to Delive…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the expanding adoption of its Population Health Management solutions with health systems across the globe, including...

Pflegetiger Adds Digital Health Ventures…

Since summer 2016, Pflegetiger has been developing its innovative concept of neighborhood care, a concept designed to make in-home care attractive for care professionals again. The company's revolutionary approach -...

Can Virtual Reality be Used to Manage Pa…

Virtual reality has emerged into popular culture with an ever-widening array of applications including clinical use in a pediatric healthcare center. Children undergo necessary yet painful and distressing medical procedures...

Free iPhone App could Guide MS Research…

For some diseases, a simple blood test is all that's needed to estimate severity or confirm a diagnosis. Not so for multiple sclerosis. No single lab test can tell doctors...

Using Social Media Big Data to Combat Pr…

Researchers at Dartmouth, Stanford University, and IBM Research, conducted a critical review of existing literature to determine whether social media big data can be used to understand communication and behavioral...

B.Braun Accelerator Call for Innovative …

B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. The company employs more than 60,000 employees in 64 countries and is looking for European...

'NHS Cyber Security Batsignal' Peer-to-P…

The two chairs of the largest independent communities of NHS digital leaders will launch the 'NHS Cyber Security Batsignal', a new peer-to-peer cyber security warning alerting system, at the first...

Giving Rookie Dads the Online Info they …

Expectant and new parents often turn to the internet for parenting prep, but it turns out that dads often don't seem to find the information they say they need about...

Artificial Intelligence to Evaluate Brai…

Researchers at the University of Helsinki and the Helsinki University Hospital (HUH), Finland, have developed software based on machine learning, which can independently interpret EEG signals from a premature infant...

FDA Approves Pill with Sensor that Digit…

The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor...

Philips Partners with Dutch Health Insur…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is collaborating with Dutch health insurer ONVZ to provide an industry first, strategic cooperation...